
Caridol250 mg
Eskayef Bangladesh Ltd.
Carisoprodol is indicated for the following use: Established/FDA-approved use Short-term (up to 2 to 3 weeks) relief of discomfort associated with acute, painful musculoskeletal conditions in adults and more.
Carisoprodol is indicated for the following use:
Carisoprodol is not indicated, and evidence does not support its use, for chronic pain conditions or musculoskeletal conditions lasting longer than 2 to 3 weeks, since most such conditions are self-limiting and long-term efficacy has not been demonstrated.
| Indication | Population | Dose |
|---|---|---|
| Acute, painful musculoskeletal conditions | Adults | 250 mg to 350 mg orally three times a day and at bedtime, for a maximum of 2 to 3 weeks |
| Acute, painful musculoskeletal conditions | Pediatric patients under 16 years | Safety and efficacy not established; not recommended |
Treatment should be limited to short-term use (up to 2 to 3 weeks) since evidence of effectiveness for more prolonged use is lacking and the risk of dependence and misuse increases with longer use (see Precautions and Warnings). Carisoprodol may be taken with or without food. Doses should not be abruptly discontinued after extended use; see Precautions and Warnings for withdrawal risk.
The most commonly reported adverse effects with Carisoprodol include:
Less common effects include tachycardia, postural hypotension, facial flushing, nausea, vomiting, hiccups, epigastric discomfort, tremor, ataxia, irritability, and insomnia.
Rare but serious effects include hypersensitivity/anaphylactoid reactions (which may occur after the first dose and can include facial flushing, swelling, weakness, and dyspnea), asthma-like reactions, eosinophilia, fever, and seizures; severe CNS and respiratory depression can occur with misuse or overdose (see Overdose Effects and Precautions and Warnings).
Carisoprodol is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.